News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
ASX Large Caps: Rates sensitive stocks rally hard; Origin Energy slumps on rejected offer
News
ASX Large Caps: ASX slumps 1.5pc as gold stocks rally on safe-haven flight; jobless rate unexpectedly up
Health & Biotech
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
Health & Biotech
Global biotech sector set to boom but where are Aussie investors?
Explainers
ASX cancer stocks guide: Here’s everything you need to know
News
ASX Small Caps Lunch Wrap: Has America’s ultimate porch pirate been found this week?
Experts
MoneyTalks: How and where to spot multibaggers, and a couple of fundie’s recommendations
News
ASX Small Caps Lunch Wrap: Who else is having trouble spelling things right today?
News
ASX Large Caps: Shares flat after strong jobs data and updates from miners; Telix tumbles 15pc on Q2 results
Tech
These tech and pharma stocks are looking to M&A to drive growth in global markets
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Health & Biotech
These were the best ASX biotechs as Health Care sprang back to life in FY23
Health & Biotech
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks up as Avita Medical gets US FDA green light
News
ASX Large Caps: Energy stocks slump, but Telstra, Woolworths, QBE touch 12-month highs
Health & Biotech
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
News
